Skip to content

Insider · CIK 0001846045

Jaime Vieser

director

Files at TCRT (Alaunos Therapeutics, Inc.), MLAC (Mountain Lake Acquisition Corp.). First filing Jan 3, 2025, latest Jan 3, 2025.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 1
$0 bought, $6,022 sold

Where the trades landed

Last year at the company this insider has traded most, with each buy and sell on the bar it happened.

TCRT: Alaunos Therapeutics, Inc.

TCRTOct 9, 2026 · close 0.79

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™

Signals

This insider’s open-market buys and sells, scored.

ScoreCompanyValueHoldingsPrice contextFiled
20Weak
TCRTsell
Alaunos Therapeutics, Inc.
$6,022
3,000 shares
-10%-

Planned sales

Form 144 notices this insider filed before selling restricted or control stock, newest first.

FiledCompanySharesValueSale datePast 3 months
Dec 31, 2024 TCRT
Alaunos Therapeutics, Inc.
3,000
0.19% of outstanding
$6,510Dec 31, 2024none

Transactions

Every row this insider has filed, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Oct 6, 2026TCRT
Alaunos Therapeutics, Inc.
AGrant or award
Common Stock
+22,669$0.74$17k70,3114 d ago
Jan 12, 2026TCRT
Alaunos Therapeutics, Inc.
AGrant or award
Common Stock
+5,839$2.89$17k32,338Jan 15, 2026
Nov 21, 2025TCRT
Alaunos Therapeutics, Inc.
AGrant or award
Common Stock
+5,340$3.16$17k26,499Nov 26, 2025
Jul 3, 2025TCRT
Alaunos Therapeutics, Inc.
AGrant or award
Common Stock
+3,400$0.00$021,159Jul 7, 2025
Jul 3, 2025TCRT
Alaunos Therapeutics, Inc.
AGrant or award
Employee Stock Option (right to buy)derivative
+6,400$0.00$06,400Jul 7, 2025
Jun 24, 2025TCRT
Alaunos Therapeutics, Inc.
POpen-market purchase
Series A-2 Convertible Preferred Stockderivative
+250$4.49$1,123250Jun 26, 2025
Apr 13, 2025TCRT
Alaunos Therapeutics, Inc.
AGrant or award
Common Stock
+17,465$0.00$043,359Apr 15, 2025
Dec 31, 2024TCRT
Alaunos Therapeutics, Inc.
SOpen-market sale
Common Stock
-2,182$2.01$4,38626,712Jan 3, 2025
Dec 31, 2024TCRT
Alaunos Therapeutics, Inc.
SOpen-market sale
Common Stock
-818$2.00$1,63625,894Jan 3, 2025
Dec 16, 2024MLAC
Mountain Lake Acquisition Corp.
POpen-market purchase
Class A Ordinary Share, par value $0.0001 per shareindirect: See Footnote
+25,000--25,000Dec 16, 2024
Dec 12, 2024MLAC
Mountain Lake Acquisition Corp.
AGrant or award
Class B ordinary shares, par value $0.0001 per sharederivativeindirect: See Footnote
+65,242--1,351,783Dec 16, 2024
Dec 16, 2024MLAC
Mountain Lake Acquisition Corp.
DDisposition to issuer
Class B ordinary shares, par value $0.0001 per sharederivativeindirect: See Footnote
-65,242--1,286,541Dec 16, 2024
Dec 16, 2024MLAC
Mountain Lake Acquisition Corp.
POpen-market purchase
Rights to receive Class A Ordinary Sharesderivativeindirect: See Footnote
+25,000--25,000Dec 16, 2024

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Jaime Vieser: insider trades and track record | InsiderTell